Guilin Layn Natural Ingredients Corp. (SHE:002166)
China · Delayed Price · Currency is CNY 9.02
-0.01 (-0.11%)
Apr 16, 2026, 3:04 PM CST
SHE:002166 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Operating Revenue | 2,044 | 1,725 | 1,484 | 1,322 | 1,006 |
Other Revenue | - | 46.5 | 9.83 | 78.78 | 46.89 |
| 2,044 | 1,772 | 1,494 | 1,401 | 1,053 | |
Revenue Growth (YoY) | 15.36% | 18.60% | 6.65% | 32.99% | 34.40% |
Cost of Revenue | 1,518 | 1,272 | 1,166 | 992.68 | 748.76 |
Gross Profit | 526.32 | 499.77 | 327.72 | 408.05 | 304.47 |
Selling, General & Admin | 224.76 | 202.63 | 192.78 | 148.63 | 121.66 |
Research & Development | 58.35 | 57.5 | 48.39 | 44.26 | 38.98 |
Other Operating Expenses | -9.12 | 6.68 | 8.38 | 5.82 | 5.36 |
Operating Expenses | 273.99 | 285.3 | 252.75 | 199.01 | 166.96 |
Operating Income | 252.32 | 214.47 | 74.97 | 209.04 | 137.52 |
Interest Expense | - | -42.24 | -32.9 | -27.72 | -24.65 |
Interest & Investment Income | 4.6 | 11.41 | 12.72 | 12.79 | 6.73 |
Currency Exchange Gain (Loss) | - | 8.76 | 1.56 | 10.47 | -3 |
Other Non Operating Income (Expenses) | -61.68 | -2.79 | 5.41 | -1.21 | -0.64 |
EBT Excluding Unusual Items | 195.24 | 189.61 | 61.77 | 203.37 | 115.96 |
Gain (Loss) on Sale of Investments | 4.25 | 2.03 | 45.35 | 35.63 | 12.54 |
Gain (Loss) on Sale of Assets | -0.13 | -0.52 | -0.71 | -0.08 | -0.81 |
Asset Writedown | 1.34 | -1.12 | -8.05 | -0.02 | - |
Other Unusual Items | - | 17.85 | 18.01 | -0.56 | 24.24 |
Pretax Income | 200.7 | 207.84 | 116.36 | 238.34 | 151.94 |
Income Tax Expense | 47.82 | 40.66 | 18.02 | 50.04 | 20.75 |
Earnings From Continuing Operations | 152.88 | 167.17 | 98.35 | 188.29 | 131.19 |
Minority Interest in Earnings | -9.76 | -4.17 | -15.84 | -9.55 | -12.75 |
Net Income | 143.12 | 163.01 | 82.51 | 178.74 | 118.44 |
Net Income to Common | 143.12 | 163.01 | 82.51 | 178.74 | 118.44 |
Net Income Growth | -12.20% | 97.56% | -53.84% | 50.91% | 37.74% |
Shares Outstanding (Basic) | 736 | 741 | 750 | 616 | 564 |
Shares Outstanding (Diluted) | 736 | 741 | 750 | 616 | 564 |
Shares Change (YoY) | -0.69% | -1.22% | 21.70% | 9.28% | -1.62% |
EPS (Basic) | 0.19 | 0.22 | 0.11 | 0.29 | 0.21 |
EPS (Diluted) | 0.19 | 0.22 | 0.11 | 0.29 | 0.21 |
EPS Growth | -11.59% | 100.00% | -62.07% | 38.09% | 40.00% |
Free Cash Flow | -1.95 | -47.37 | -313.37 | -377.38 | -152.58 |
Free Cash Flow Per Share | -0.00 | -0.06 | -0.42 | -0.61 | -0.27 |
Dividend Per Share | - | 0.100 | 0.200 | 0.100 | - |
Dividend Growth | - | -50.00% | 100.00% | - | - |
Gross Margin | 25.75% | 28.21% | 21.94% | 29.13% | 28.91% |
Operating Margin | 12.35% | 12.11% | 5.02% | 14.92% | 13.06% |
Profit Margin | 7.00% | 9.20% | 5.52% | 12.76% | 11.24% |
Free Cash Flow Margin | -0.10% | -2.67% | -20.98% | -26.94% | -14.49% |
EBITDA | 380.08 | 312.61 | 159.95 | 280.52 | 192.93 |
EBITDA Margin | 18.60% | 17.64% | 10.71% | 20.03% | 18.32% |
D&A For EBITDA | 127.76 | 98.14 | 84.98 | 71.47 | 55.41 |
EBIT | 252.32 | 214.47 | 74.97 | 209.04 | 137.52 |
EBIT Margin | 12.35% | 12.11% | 5.02% | 14.92% | 13.06% |
Effective Tax Rate | 23.82% | 19.56% | 15.48% | 21.00% | 13.66% |
Revenue as Reported | - | 1,772 | 1,494 | 1,401 | 1,053 |
Advertising Expenses | - | 8.77 | 6.53 | 6.09 | 4.08 |
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.